Although their mechanism is not based on direct peptidase inhibition, their relevance in obesity treatment highlights the importance of targeting peptide-mediated metabolic pathways, complementing the role of peptidase inhibitors in modulating metabolic processes. Here, LAP3 is linked to obesity disorder.